Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 96 entries
Sorted by: Best Match Show Resources per page
Sequence diversity and potential recombination events in the coat protein gene of Apple stem pitting virus

STEM and diversity

Kaczanowski S, Siedlecki P.
GSID: iJGw5Ptdt6MJ
B Komorowska, P Siedlecki, S Kaczanowski… - Virus research, 2011 - Elsevier

The variability of the Apple stem pitting virus (ASPV) coat protein (CP) gene was investigated. The CP gene of ten virus isolates from apple and pear trees was sequenced. Comparison …

Cite
Komorowska, B., Siedlecki, P., Kaczanowski, S., Hasiów-Jaroszewska, B., & Malinowski, T. (2011). Sequence diversity and potential recombination events in the coat protein gene of Apple stem pitting virus. Virus research, 158(1-2), 263-267.
Komorowska, Beata, et al. "Sequence diversity and potential recombination events in the coat protein gene of Apple stem pitting virus." Virus research 158.1-2 (2011): 263-267.
Copy Download .nbib Format: MLA
An individual differences analysis of memory control.

Journal of memory and language

Salthouse TA, Siedlecki KL, Krueger LE.
PMID: 24347812
J Mem Lang. 2006 Jul 01;55(1). doi: 10.1016/j.jml.2006.03.006.

Performance on a wide variety of memory tasks can be hypothesized to be influenced by processes associated with controlling the contents of memory. In this project 328 adults ranging from 18 to 93 years of age performed six tasks...

Cite
Salthouse TA, Siedlecki KL, Krueger LE. An individual differences analysis of memory control. J Mem Lang. 2006;55(1)doi: 10.1016/j.jml.2006.03.006.
Salthouse, T. A., Siedlecki, K. L., & Krueger, L. E. (2006). An individual differences analysis of memory control. Journal of memory and language, 55(1), . https://doi.org/10.1016/j.jml.2006.03.006
Salthouse, Timothy A, et al. "An individual differences analysis of memory control." Journal of memory and language vol. 55,1 (2006). doi: https://doi.org/10.1016/j.jml.2006.03.006
Salthouse TA, Siedlecki KL, Krueger LE. An individual differences analysis of memory control. J Mem Lang. 2006 Jul 01;55(1). doi: 10.1016/j.jml.2006.03.006. PMID: 24347812; PMCID: PMC3859462.
Copy Download .nbib Format: NLM
Open Drug Discovery Toolkit (ODDT): a new open-source player in the drug discovery field.

Journal of cheminformatics

Wójcikowski M, Zielenkiewicz P, Siedlecki P.
PMID: 26101548
J Cheminform. 2015 Jun 22;7:26. doi: 10.1186/s13321-015-0078-2. eCollection 2015.

BACKGROUND: There has been huge progress in the open cheminformatics field in both methods and software development. Unfortunately, there has been little effort to unite those methods and software into one package. We here describe the Open Drug Discovery...

Cite
Wójcikowski M, Zielenkiewicz P, Siedlecki P. Open Drug Discovery Toolkit (ODDT): a new open-source player in the drug discovery field. J Cheminform. 2015;7:26doi: 10.1186/s13321-015-0078-2.
Wójcikowski, M., Zielenkiewicz, P., & Siedlecki, P. (2015). Open Drug Discovery Toolkit (ODDT): a new open-source player in the drug discovery field. Journal of cheminformatics, 726. https://doi.org/10.1186/s13321-015-0078-2
Wójcikowski, Maciej, et al. "Open Drug Discovery Toolkit (ODDT): a new open-source player in the drug discovery field." Journal of cheminformatics vol. 7 (2015): 26. doi: https://doi.org/10.1186/s13321-015-0078-2
Wójcikowski M, Zielenkiewicz P, Siedlecki P. Open Drug Discovery Toolkit (ODDT): a new open-source player in the drug discovery field. J Cheminform. 2015 Jun 22;7:26. doi: 10.1186/s13321-015-0078-2. eCollection 2015. PMID: 26101548; PMCID: PMC4475766.
Copy Download .nbib Format: NLM
An engineered micropattern to reduce bacterial colonization, platelet adhesion and fibrin sheath formation for improved biocompatibility of central venous catheters.

Clinical and translational medicine

May RM, Magin CM, Mann EE, Drinker MC, Fraser JC, Siedlecki CA, Brennan AB, Reddy ST.
PMID: 25852825
Clin Transl Med. 2015 Feb 26;4:9. doi: 10.1186/s40169-015-0050-9. eCollection 2015.

BACKGROUND: Catheter-related bloodstream infections (CRBSIs) and catheter-related thrombosis (CRT) are common complications of central venous catheters (CVC), which are used to monitor patient health and deliver medications. CVCs are subject to protein adsorption and platelet adhesion as well as...

Cite
May RM, Magin CM, Mann EE, et al. An engineered micropattern to reduce bacterial colonization, platelet adhesion and fibrin sheath formation for improved biocompatibility of central venous catheters. Clin Transl Med. 2015;4:9doi: 10.1186/s40169-015-0050-9.
May, R. M., Magin, C. M., Mann, E. E., Drinker, M. C., Fraser, J. C., Siedlecki, C. A., Brennan, A. B., & Reddy, S. T. (2015). An engineered micropattern to reduce bacterial colonization, platelet adhesion and fibrin sheath formation for improved biocompatibility of central venous catheters. Clinical and translational medicine, 49. https://doi.org/10.1186/s40169-015-0050-9
May, Rhea M, et al. "An engineered micropattern to reduce bacterial colonization, platelet adhesion and fibrin sheath formation for improved biocompatibility of central venous catheters." Clinical and translational medicine vol. 4 (2015): 9. doi: https://doi.org/10.1186/s40169-015-0050-9
May RM, Magin CM, Mann EE, Drinker MC, Fraser JC, Siedlecki CA, Brennan AB, Reddy ST. An engineered micropattern to reduce bacterial colonization, platelet adhesion and fibrin sheath formation for improved biocompatibility of central venous catheters. Clin Transl Med. 2015 Feb 26;4:9. doi: 10.1186/s40169-015-0050-9. eCollection 2015. PMID: 25852825; PMCID: PMC4385044.
Copy Download .nbib Format: NLM
Three-dimensional ray tracing on Delaunay-based reconstructed surfaces.

Applied optics

Ortiz S, Siedlecki D, Remon L, Marcos S.
PMID: 19593339
Appl Opt. 2009 Jul 10;48(20):3886-93. doi: 10.1364/ao.48.003886.

A method of ray tracing for free-form optical surfaces has been developed. The ray tracing through such surfaces is based on Delaunay triangulation of the discrete data of the surface and is related to finite-element modeling. Some numerical examples...

Cite
Ortiz S, Siedlecki D, Remon L, et al. Three-dimensional ray tracing on Delaunay-based reconstructed surfaces. Appl Opt. 2009;48(20):3886-93doi: 10.1364/ao.48.003886.
Ortiz, S., Siedlecki, D., Remon, L., & Marcos, S. (2009). Three-dimensional ray tracing on Delaunay-based reconstructed surfaces. Applied optics, 48(20), 3886-93. https://doi.org/10.1364/ao.48.003886
Ortiz, Sergio, et al. "Three-dimensional ray tracing on Delaunay-based reconstructed surfaces." Applied optics vol. 48,20 (2009): 3886-93. doi: https://doi.org/10.1364/ao.48.003886
Ortiz S, Siedlecki D, Remon L, Marcos S. Three-dimensional ray tracing on Delaunay-based reconstructed surfaces. Appl Opt. 2009 Jul 10;48(20):3886-93. doi: 10.1364/ao.48.003886. PMID: 19593339.
Copy Download .nbib Format: NLM
Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy.

Sarcoma

Przybyl J, Jurkowska M, Rutkowski P, Debiec-Rychter M, Siedlecki JA.
PMID: 22550415
Sarcoma. 2012;2012:249219. doi: 10.1155/2012/249219. Epub 2012 Mar 25.

Synovial sarcoma (SS), an aggressive type of soft tissue tumor, occurs mostly in adolescents and young adults. The origin and molecular mechanism of the development of SS remain only partially known. Over 90% of SS cases are characterized by...

Cite
Przybyl J, Jurkowska M, Rutkowski P, et al. Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy. Sarcoma. 2012;2012:249219doi: 10.1155/2012/249219.
Przybyl, J., Jurkowska, M., Rutkowski, P., Debiec-Rychter, M., & Siedlecki, J. A. (2012). Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy. Sarcoma, 2012249219. https://doi.org/10.1155/2012/249219
Przybyl, Joanna, et al. "Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy." Sarcoma vol. 2012 (2012): 249219. doi: https://doi.org/10.1155/2012/249219
Przybyl J, Jurkowska M, Rutkowski P, Debiec-Rychter M, Siedlecki JA. Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy. Sarcoma. 2012;2012:249219. doi: 10.1155/2012/249219. Epub 2012 Mar 25. PMID: 22550415; PMCID: PMC3329658.
Copy Download .nbib Format: NLM
Chloroplast DNA synthesis in light and dark grown cultured Nicotiana tabacum cells as determined by molecular hybridization.

Plant cell reports

Cannon G, Heinhorst S, Siedlecki J, Weissbach A.
PMID: 24253680
Plant Cell Rep. 1985 Apr;4(2):41-5. doi: 10.1007/BF00269202.

A simple method using molecular hybridization was devised to quantitatively measure chloroplast DNA synthesis in vivo. Total cellular DNA isolated from Nicotiana tabacum suspension cells, labeled with (3)H-thymidine, was hybridized to nitrocellulose membrane-bound cloned chloroplast DNA (ct DNA) fragments....

Cite
Cannon G, Heinhorst S, Siedlecki J, et al. Chloroplast DNA synthesis in light and dark grown cultured Nicotiana tabacum cells as determined by molecular hybridization. Plant Cell Rep. 1985;4(2):41-5doi: 10.1007/BF00269202.
Cannon, G., Heinhorst, S., Siedlecki, J., & Weissbach, A. (1985). Chloroplast DNA synthesis in light and dark grown cultured Nicotiana tabacum cells as determined by molecular hybridization. Plant cell reports, 4(2), 41-5. https://doi.org/10.1007/BF00269202
Cannon, G, et al. "Chloroplast DNA synthesis in light and dark grown cultured Nicotiana tabacum cells as determined by molecular hybridization." Plant cell reports vol. 4,2 (1985): 41-5. doi: https://doi.org/10.1007/BF00269202
Cannon G, Heinhorst S, Siedlecki J, Weissbach A. Chloroplast DNA synthesis in light and dark grown cultured Nicotiana tabacum cells as determined by molecular hybridization. Plant Cell Rep. 1985 Apr;4(2):41-5. doi: 10.1007/BF00269202. PMID: 24253680.
Copy Download .nbib Format: NLM
Polymorphisms of DNA repair and oxidative stress genes in B-cell lymphoma patients.

Biomedical reports

Fabisiewicz A, Pacholewicz K, Paszkiewicz-Kozik E, Walewski J, Siedlecki JA.
PMID: 24648912
Biomed Rep. 2013 Jan;1(1):151-155. doi: 10.3892/br.2012.31. Epub 2012 Oct 25.

The purpose of the study was to investigate the possible association between

Cite
Fabisiewicz A, Pacholewicz K, Paszkiewicz-Kozik E, et al. Polymorphisms of DNA repair and oxidative stress genes in B-cell lymphoma patients. Biomed Rep. 2012;1(1):151-155doi: 10.3892/br.2012.31.
Fabisiewicz, A., Pacholewicz, K., Paszkiewicz-Kozik, E., Walewski, J., & Siedlecki, J. A. (2013). Polymorphisms of DNA repair and oxidative stress genes in B-cell lymphoma patients. Biomedical reports, 1(1), 151-155. https://doi.org/10.3892/br.2012.31
Fabisiewicz, Anna, et al. "Polymorphisms of DNA repair and oxidative stress genes in B-cell lymphoma patients." Biomedical reports vol. 1,1 (2013): 151-155. doi: https://doi.org/10.3892/br.2012.31
Fabisiewicz A, Pacholewicz K, Paszkiewicz-Kozik E, Walewski J, Siedlecki JA. Polymorphisms of DNA repair and oxidative stress genes in B-cell lymphoma patients. Biomed Rep. 2013 Jan;1(1):151-155. doi: 10.3892/br.2012.31. Epub 2012 Oct 25. PMID: 24648912; PMCID: PMC3956729.
Copy Download .nbib Format: NLM
Evaluation of distant sequelae of breast cancer treatment among patients after breast-conserving surgery depending on the type of intervention in the axillary fossa.

Contemporary oncology (Poznan, Poland)

Głowacka-Mrotek I, Tarkowska M, Nowikiewicz T, Siedlecki Z, Zegarski W, Hagner W.
PMID: 30783388
Contemp Oncol (Pozn). 2018;22(4):240-246. doi: 10.5114/wo.2018.82643. Epub 2018 Dec 31.

AIM OF THE STUDY: The goal of this work was to assess upper-limb sequelae among patients undergoing breast-conserving therapy (BCT) for breast cancer 5-6 years after the surgical procedure.MATERIAL AND METHODS: A controlled clinical study was conducted on 128...

Cite
Głowacka-Mrotek I, Tarkowska M, Nowikiewicz T, et al. Evaluation of distant sequelae of breast cancer treatment among patients after breast-conserving surgery depending on the type of intervention in the axillary fossa. Contemp Oncol (Pozn). 2018;22(4):240-246doi: 10.5114/wo.2018.82643.
Głowacka-Mrotek, I., Tarkowska, M., Nowikiewicz, T., Siedlecki, Z., Zegarski, W., & Hagner, W. (2018). Evaluation of distant sequelae of breast cancer treatment among patients after breast-conserving surgery depending on the type of intervention in the axillary fossa. Contemporary oncology (Poznan, Poland), 22(4), 240-246. https://doi.org/10.5114/wo.2018.82643
Głowacka-Mrotek, Iwona, et al. "Evaluation of distant sequelae of breast cancer treatment among patients after breast-conserving surgery depending on the type of intervention in the axillary fossa." Contemporary oncology (Poznan, Poland) vol. 22,4 (2018): 240-246. doi: https://doi.org/10.5114/wo.2018.82643
Głowacka-Mrotek I, Tarkowska M, Nowikiewicz T, Siedlecki Z, Zegarski W, Hagner W. Evaluation of distant sequelae of breast cancer treatment among patients after breast-conserving surgery depending on the type of intervention in the axillary fossa. Contemp Oncol (Pozn). 2018;22(4):240-246. doi: 10.5114/wo.2018.82643. Epub 2018 Dec 31. PMID: 30783388; PMCID: PMC6377421.
Copy Download .nbib Format: NLM
The ethics of peer review: What to know before saying "yes".

Nursing

Siedlecki SL.
PMID: 26580113
Nursing. 2015 Dec;45(12):51-4. doi: 10.1097/01.NURSE.0000473395.43930.46.

No abstract available.

Cite
Siedlecki SL. The ethics of peer review: What to know before saying "yes". Nursing. 2015;45(12):51-4doi: 10.1097/01.NURSE.0000473395.43930.46.
Siedlecki, S. L. (2015). The ethics of peer review: What to know before saying "yes". Nursing, 45(12), 51-4. https://doi.org/10.1097/01.NURSE.0000473395.43930.46
Siedlecki, Sandra L. "The ethics of peer review: What to know before saying "yes"." Nursing vol. 45,12 (2015): 51-4. doi: https://doi.org/10.1097/01.NURSE.0000473395.43930.46
Siedlecki SL. The ethics of peer review: What to know before saying "yes". Nursing. 2015 Dec;45(12):51-4. doi: 10.1097/01.NURSE.0000473395.43930.46. PMID: 26580113.
Copy Download .nbib Format: NLM
TET2 Promoter DNA Methylation and Expression Analysis in Pediatric B-cell Acute Lymphoblastic Leukemia.

Hematology reports

Musialik E, Bujko M, Wypych A, Matysiak M, Siedlecki JA.
PMID: 24711921
Hematol Rep. 2014 Mar 28;6(1):5333. doi: 10.4081/hr.2014.5333. eCollection 2014 Jan 29.

TET2 is a novel tumor suppressor gene involved in several hematological malignancies of myeloid and lymphoid origin. Besides loss-of-function mutations and deletions, hypermethylation of the CpG island at the TET2 promoter was found in human cancer. Previous analysis revealed...

Cite
Musialik E, Bujko M, Wypych A, et al. TET2 Promoter DNA Methylation and Expression Analysis in Pediatric B-cell Acute Lymphoblastic Leukemia. Hematol Rep. 2014;6(1):5333doi: 10.4081/hr.2014.5333.
Musialik, E., Bujko, M., Wypych, A., Matysiak, M., & Siedlecki, J. A. (2014). TET2 Promoter DNA Methylation and Expression Analysis in Pediatric B-cell Acute Lymphoblastic Leukemia. Hematology reports, 6(1), 5333. https://doi.org/10.4081/hr.2014.5333
Musialik, Ewa, et al. "TET2 Promoter DNA Methylation and Expression Analysis in Pediatric B-cell Acute Lymphoblastic Leukemia." Hematology reports vol. 6,1 (2014): 5333. doi: https://doi.org/10.4081/hr.2014.5333
Musialik E, Bujko M, Wypych A, Matysiak M, Siedlecki JA. TET2 Promoter DNA Methylation and Expression Analysis in Pediatric B-cell Acute Lymphoblastic Leukemia. Hematol Rep. 2014 Mar 28;6(1):5333. doi: 10.4081/hr.2014.5333. eCollection 2014 Jan 29. PMID: 24711921; PMCID: PMC3977158.
Copy Download .nbib Format: NLM
Cell-free DNA .

Tumori

Kozak K, Kowalik A, Gos A, Wasag B, Lugowska I, Jurkowska M, Krawczynska N, Kosela-Paterczyk H, Switaj T, Teterycz P, Klimczak A, Siedlecki JA, Chlopek M, Kalisz J, Limon J, Rutkowski P.
PMID: 32026754
Tumori. 2020 Feb 06;300891619900928. doi: 10.1177/0300891619900928. Epub 2020 Feb 06.

OBJECTIVE: We assessed the status of the METHODS: cfDNA in patients with RESULTS: cfDNA V600E was detected in the plasma of 48/62 (77%) patients at baseline and in 18/62 (29%) patients after 4-8 weeks of treatment. Patients positive for...

Cite
Kozak K, Kowalik A, Gos A, et al. Cell-free DNA . Tumori. 2020;300891619900928doi: 10.1177/0300891619900928.
Kozak, K., Kowalik, A., Gos, A., Wasag, B., Lugowska, I., Jurkowska, M., Krawczynska, N., Kosela-Paterczyk, H., Switaj, T., Teterycz, P., Klimczak, A., Siedlecki, J. A., Chlopek, M., Kalisz, J., Limon, J., & Rutkowski, P. (2020). Cell-free DNA . Tumori, 300891619900928. https://doi.org/10.1177/0300891619900928
Kozak, Katarzyna, et al. "Cell-free DNA ." Tumori vol. (2020): 300891619900928. doi: https://doi.org/10.1177/0300891619900928
Kozak K, Kowalik A, Gos A, Wasag B, Lugowska I, Jurkowska M, Krawczynska N, Kosela-Paterczyk H, Switaj T, Teterycz P, Klimczak A, Siedlecki JA, Chlopek M, Kalisz J, Limon J, Rutkowski P. Cell-free DNA . Tumori. 2020 Feb 06;300891619900928. doi: 10.1177/0300891619900928. Epub 2020 Feb 06. PMID: 32026754.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 96 entries